Nölting, S.; Kuttner, A.; Lauseker, M.; Vogeser, M.; Haug, A.; Herrmann, K.A.; Hoffmann, J.N.; Spitzweg, C.; Göke, B.; Auernhammer, C.J.
Chromogranin A as Serum Marker for Gastroenteropancreatic Neuroendocrine Tumors: A Single Center Experience and Literature Review. Cancers 2012, 4, 141-155.
https://doi.org/10.3390/cancers4010141
AMA Style
Nölting S, Kuttner A, Lauseker M, Vogeser M, Haug A, Herrmann KA, Hoffmann JN, Spitzweg C, Göke B, Auernhammer CJ.
Chromogranin A as Serum Marker for Gastroenteropancreatic Neuroendocrine Tumors: A Single Center Experience and Literature Review. Cancers. 2012; 4(1):141-155.
https://doi.org/10.3390/cancers4010141
Chicago/Turabian Style
Nölting, Svenja, Axel Kuttner, Michael Lauseker, Michael Vogeser, Alexander Haug, Karin A. Herrmann, Johannes N. Hoffmann, Christine Spitzweg, Burkhard Göke, and Christoph J. Auernhammer.
2012. "Chromogranin A as Serum Marker for Gastroenteropancreatic Neuroendocrine Tumors: A Single Center Experience and Literature Review" Cancers 4, no. 1: 141-155.
https://doi.org/10.3390/cancers4010141
APA Style
Nölting, S., Kuttner, A., Lauseker, M., Vogeser, M., Haug, A., Herrmann, K. A., Hoffmann, J. N., Spitzweg, C., Göke, B., & Auernhammer, C. J.
(2012). Chromogranin A as Serum Marker for Gastroenteropancreatic Neuroendocrine Tumors: A Single Center Experience and Literature Review. Cancers, 4(1), 141-155.
https://doi.org/10.3390/cancers4010141